Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Inozyme Pharma, Inc. (INZY) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 2,319 shares @ $3.57, valued at $8.3k
08/03/2023 4 Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 119,048 shares @ $4.8, valued at $571.4k
Bought 714,285 shares @ $4.8, valued at $3.4M
08/03/2023 4 Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 119,048 shares @ $4.8, valued at $571.4k
Bought 714,285 shares @ $4.8, valued at $3.4M
05/15/2023 4 Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 219,230 shares @ $6.48, valued at $1.4M
Bought 228,702 shares @ $6.25, valued at $1.4M
05/03/2023 4 Bolte Axel (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 100,000 options to buy @ $5.81, valued at $581k
04/04/2023 4 Treco Douglas A (CEO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 800,000 options to buy @ $0
Granted 100,000 restricted stock units @ $0
04/04/2023 4 Bolte Axel (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 4,806 shares @ $2.21, valued at $10.6k
04/04/2023 4 Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 979 shares @ $2.21, valued at $2.2k
04/04/2023 4 Winton Matthew (COO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 250,000 options to buy @ $5.39, valued at $1.3M
04/04/2023 3 Winton Matthew (COO) has filed a Form 3 on Inozyme Pharma, Inc.
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2022 4 Bolte Axel (CEO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 3,315 shares @ $2.28, valued at $7.6k
10/04/2022 4 Bjarke Henric Bjorn (SVP, COO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 3,315 shares @ $2.28, valued at $7.6k
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Sullivan Lynne Marie (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 9,367 options to buy @ $4.38, valued at $41k
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Edwards Martin (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 9,367 options to buy @ $4.38, valued at $41k
06/14/2022 4 DIAZ REINALDO M (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 9,367 options to buy @ $4.38, valued at $41k
06/14/2022 4 Bhagat Sarah M (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 9,367 options to buy @ $4.38, valued at $41k
04/21/2022 4 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 1,355,000 shares @ $3.69, valued at $5M
04/20/2022 4 Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 1,070,000 shares @ $3.69, valued at $3.9M
04/20/2022 4 Bjarke Henric Bjorn (SVP, COO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 27,100 shares @ $3.69, valued at $100k
04/20/2022 4 Bolte Axel (CEO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 67,750 shares @ $3.69, valued at $250k
04/20/2022 4 Hopfner Robert Lorne (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 1,070,000 shares @ $3.69, valued at $3.9M
04/20/2022 4 Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Bought 27,100 shares @ $3.69, valued at $100k
03/22/2022 4 Subramanian Sanjay (SVP, CFO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 180,000 options to buy @ $3.96, valued at $712.8k
03/22/2022 3 Subramanian Sanjay (SVP, CFO) has filed a Form 3 on Inozyme Pharma, Inc.
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2021 4 Bolte Axel (CEO) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Sold 66,788 shares @ $0.0001, valued at $6.7
Exercised 66,788 options to buy @ $0.98, valued at $65.5k
06/25/2021 4 Bhagat Sarah M (Director) has filed a Form 4 on Inozyme Pharma, Inc.
Txns: Granted 9,367 options to buy @ $17.12, valued at $160.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy